Results 171 to 180 of about 144,968 (305)

Prognostic relevance of ABO blood group system in non-metastatic renal cell carcinoma: An analysis of two independent European cohorts with long-term follow-up

open access: hybrid, 2021
Dominik A. Barth   +16 more
openalex   +1 more source

Exploring the influence of blood donor sex on outcomes in Australian very low birth weight infants

open access: yesVox Sanguinis, EarlyView.
Abstract Background and Objectives Despite many known benefits of red blood cell (RBC) transfusions for very low birth weight (VLBW) infants, there is increasing concern that they may be associated with adverse clinical outcomes and that donor characteristics (including donor sex) could contribute to these adverse outcomes.
Georgina Jacko   +4 more
wiley   +1 more source

The Spectrum of ABO and Rhesus Blood Group Systems in a Blood Center in Southern Karnataka

open access: diamond, 2023
Rashmi Budha   +3 more
openalex   +1 more source

Production of viable and functional neutrophils in granulocyte concentrates with the Reveos automated system

open access: yesVox Sanguinis, EarlyView.
Abstract Background and Objectives Granulocyte transfusions may benefit patients with neutropaenia and life‐threatening infections unresponsive to antimicrobial therapies. Current aphaeresis‐based granulocyte concentrate (GC) production requires donor stimulation and hydroxyethyl starch (HES), which raises safety and supply concerns.
Sahra Fonseca   +4 more
wiley   +1 more source

Unifying serological testing for cold agglutinins

open access: yesVox Sanguinis, EarlyView.
Abstract Background and Objectives Cold agglutinins (CAs) are immunoglobulin M autoantibodies that optimally bind to red blood cells at low temperatures. The clinical significance of CAs is usually characterized by the CA titre and thermal amplitude. However, there is no consensus on the optimal testing strategy.
Marit Jalink   +34 more
wiley   +1 more source

In vitro quality of whole blood‐derived red cell concentrates collected, processed and stored in a blood bag set plasticized with di (2‐ethylhexyl) terephthalate

open access: yesVox Sanguinis, EarlyView.
Abstract Background and Objectives Due to toxicity concerns, di(2‐ethylhexyl) phthalate (DEHP)—the most used plasticizer in polyvinyl chloride (PVC) whole blood (WB) collection and processing bag sets—will be effectively prohibited in medical devices in Europe from 2030. Removal of DEHP will primarily impact the in vitro quality of red blood cell (RBC)
Tatiana Stephenson   +7 more
wiley   +1 more source

Current advances 2024: A critical review of selected topics by the Association for the Advancement of Blood and Biotherapies (AABB) Clinical Transfusion Medicine Committee

open access: yes
Transfusion, EarlyView.
Elizabeth P. Crowe   +21 more
wiley   +1 more source

The public health impacts of mining in Australia

open access: yesMedical Journal of Australia, EarlyView.
Summary Australia is rich in minerals of commercial interest along with oil and gas, and mining activities are carried out in almost all states and territories. The public health impacts of mining on the Australian general population need to be addressed to enable a comprehensive cost–benefit assessment of these activities balanced against their ...
Javier Cortes‐Ramirez   +3 more
wiley   +1 more source

Optimal Time Period to Achieve Temperature Stabilisation After Total Contact Cast (TCC) Removal for Assessing Dermal Temperatures in Active Charcot Neuro‐Osteoarthropathy

open access: yesJournal of Foot and Ankle Research, Volume 18, Issue 3, September 2025.
ABSTRACT Background Dermal temperature differentials between limbs are used to monitor disease progression and support safe withdrawal of immobilisation in Charcot neuro‐osteoarthropathy (CNO). Despite the wide clinical use of dermal thermometry, there is a lack of evidence on the optimal temperature stabilisation period after removal of immobilisation
Justin Bradley   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy